Determination of Fluoxetine and Its Metabolite Norfluoxetine in Human Liver Microsomes by Reversed-Phase HPLC in Vitro.

ZQ Liu,ZN Cheng,W Wang,ZR Tan,DS Ou-Yang,HH Zhou
2000-01-01
Abstract:AIM: A high-performance liquid chromatography (HPLC) method was developed for the determination of fluoxetine (FLU) and its metabolite norfluoxetine (N-FLU) in human liver microsomes in vitro. METHODS: An incubation buffer containing human liver microsomes, NADPH-generating system, and FLU, after termination of enzyme reaction and addition of nortriptyline (NOR) as internal standard (IS), was extracted with n-hexane/acetonitrile, and separated on a reversed-phase ODS column. Detection was achieved at 226 nm by ultraviolet detector (UV). RESULTS: The limit of detection was 5 mug/L for both FLU and N-FLU. No potential interference was found. The method provides recoveries of up to 94 % - 104 % and acceptable coefficients of variation were found for both within-run ( < 7.8 %) and day to day (< 9.1 %) assays. CONCLUSION: This method is rapid, sensitive, and simple for studying the metabolism of FLU and N-FLU.
What problem does this paper attempt to address?